IDH1 and astrocytoma (excluding glioblastoma): In the joint cohort with known molecular status, including both IDH-mutation and 1p19q codeletion (N = 135), the specificity for IDH-mut astrocytomas was 97.6% and the sensitivity was 26.4%.